| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 7.438 | 11.974 | 40.950 | 105.839 | 311.786 | 144.006 | 175.043 | 420.829 |
| Total Income - EUR | - | 0 | 7.455 | 11.974 | 41.985 | 107.445 | 318.005 | 144.006 | 188.827 | 420.872 |
| Total Expenses - EUR | - | 0 | 2.080 | 7.824 | 11.220 | 58.198 | 127.783 | 109.305 | 172.223 | 322.326 |
| Gross Profit/Loss - EUR | - | 0 | 5.375 | 4.150 | 30.765 | 49.247 | 190.222 | 34.702 | 16.605 | 98.547 |
| Net Profit/Loss - EUR | - | 0 | 5.152 | 3.791 | 29.745 | 48.241 | 187.100 | 33.261 | 14.716 | 86.701 |
| Employees | - | 0 | 0 | 0 | 3 | 4 | 5 | 4 | 5 | 8 |
Check the financial reports for the company - Endorfina Concept S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 2.122 | 1.366 | 68 | 79.591 | 66.305 | 64.123 | 84.917 | 433.390 |
| Current Assets | - | 45 | 4.072 | 9.090 | 48.876 | 55.000 | 167.312 | 60.508 | 52.580 | 54.323 |
| Inventories | - | 0 | 943 | 925 | 907 | 1.341 | 0 | 0 | 0 | 439 |
| Receivables | - | 45 | 287 | 304 | 31.128 | 45.439 | 152.659 | 57.359 | 49.367 | 46.423 |
| Cash | - | 0 | 2.842 | 7.861 | 16.841 | 8.220 | 14.653 | 3.148 | 3.213 | 7.461 |
| Shareholders Funds | - | 45 | 5.195 | 8.891 | 29.796 | 77.472 | 177.821 | 87.331 | 15.023 | 96.664 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 0 | 998 | 1.566 | 19.149 | 51.093 | 55.796 | 37.300 | 122.474 | 391.049 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 6.026 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7111 - 7111" | |||||||||
| CAEN Financial Year |
7111
|
|||||||||
Comments - Endorfina Concept S.r.l.